Paris and Boston, April 30, 2026 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that it has published its Annual Financial Report for the year ended December 31, 2025 and filed it with the Autorité des Marchés Financiers (AMF) on April 30, 2026.
This report can be consulted on the Mauna Kea Technologies website, in accordance with current regulations. It can be consulted or downloaded at www.maunakeatech.com in the Investors > Financials, as well as on the AMF website (www.amf-france.org).
***
Upcoming events:
- 2026 Annual General Meeting: June 4, 2026
- Q2 2026 Sales: July 21, 2026
- 2026 Half-Year Results: October 8, 2026
- Q3 2026 Sales: October 20, 2026
